Showing results (4481-4490 of 27,716) with videos related to
Sort By:
Pageof 2,772
Vaccine|October 25, 2011
Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database studyJulia Stowe, Nick Andrews, Phil Bryan, et al.Vaccine|October 18, 2011
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trialGerald Aichinger, Hartmut J Ehrlich, John G Aaskov, et al.Vaccine|October 18, 2011
Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipelineMatthew M Davis, Amy T Butchart, John R C Wheeler, et al.Vaccine|November 15, 2011
Survey of national immunization programs and vaccine coverage rates in Asia Pacific countriesChun-Yi Lu, Mathuram Santosham, Vaccine|November 15, 2011
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002-2008Susan K Duderstadt, Charles E Rose, Theresa M Real, et al.Vaccine|October 15, 2011
Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replicationSuresh Pallikkuth, Kenneth Rogers, Francois Villinger, et al.Vaccine|January 1, 1993
Comparison of live attenuated and inactivated influenza vaccines in schoolchildren in Russia: I. Safety and efficacy in two Moscow schools, 1987/88A N Slepushkin, N P Obrosova-Serova, E I Burtseva, et al.Vaccine|January 1, 1993
Principles of selective inactivation of viral genome. VIII. The influence of beta-propiolactone on immunogenic and protective activities of influenza virusE I Budowsky, Smirnov YuA, S F ShenderovichVaccine|January 1, 1993
Identification of the flagellar antigens of Vibrio cholerae El Tor and their role in protectionV B Sinha, A Jacob, R Srivastava, et al.Pageof 2,772